Prospective Research Rare Kidney Stones (ProRKS)

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorMayo Clinic

About this trial

The purpose of this study is to determine the natural history of the hereditary forms of nephrolithiasis and chronic kidney disease (CKD), primary hyperoxaluria (PH), cystinuria, Dent disease and adenine phosphoribosyltransferase deficiency (APRTd) and acquired enteric hyperoxaluria (EH). The investigator will measure blood and urinary markers of inflammation and determine relationship to the disease course. Cross-comparisons among the disorders will allow us to better evaluate mechanisms of renal dysfunction in these disorders.

Eligibility criteria

Qualifiers

Diagnosis of primary hyperoxaluria

Diagnosis of enteric hyperoxaluria

Diagnosis of Dent Disease

Diagnosis of Cystinuria

Disqualifiers

Prior renal failure

History of liver and/or kidney transplant.

Trial design

Treatments tested in this trial

  • Not listed

Trial groups

220 Participants
are grouped into 7 trial groups

7

Trial groups

See each trial group below.

Sponsors and collaborators